Poseida Therapeutics, Inc.

New Filing
CIK: 0001661460·Biotechnology·DELAWARE·Filed: Aug 11, 2023
Total Offering

$24,999,999

Amount Sold

$24,999,999

Investors

1

First Sale

Aug 7, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Mark J. Gergen
Related Person
Johanna M. Mylet
Related Person
Harry J. Leonhardt
Related Person
Brent Warner
Related Person
Kristin Yarema
Related Person
Rafael Amado
Related Person
Charles M. Baum
Related Person
Cynthia Collins
Related Person
Luke Corning
Related Person
Marcea B. Lloyd
Related Person
John Schmid
Related Person

Company

Poseida Therapeutics, Inc.

9390 TOWNE CENTRE DRIVE

SAN DIEGO, CA, 92121

858-779-3100

SEC Filing

0001661460-23-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free